前收市價 | 3.4000 |
開市 | 1.3000 |
買盤 | 0.3500 |
賣出價 | 1.6000 |
拍板 | 65.00 |
到期日 | 2024-07-19 |
今日波幅 | 1.3000 - 1.3000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 24 |
Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
Amgen's (AMGN) Imdelltra is the first DLL3-targeting BiTE therapy that activates the patient's own T cells to attack DLL3-expressing tumor cells.
Kodiak (KOD) reports better-than-expected first-quarter 2024 results and provides updates regarding its pipeline development plans.